Legal Opinion
Inphi Corporation v. Netlist, Inc.
Court of Appeals for the Federal Circuit
Decided November 13, 2015No. 2015-1179PublishedCited by 15 opinions
1Opinion of the Court
O’Malley, Circuit Judge.
Netlist, Inc. (“Netlist”) is the assignee of U.S. Patent No. 7,532,537 (“the '537 patent”). Inphi Corporation (“Inphi”) filed a request for inter partes reexamination 1 on June 9, 2010. The examiner rejected claims 1-9, 12-31, and 34-44 as obvious in view of the prior art. In order to overcome this rejection, Netlist amended its claims, narrowing them. Thereafter, the examiner withdrew its rejection of the claims and issued a final decision.
Inphi then filed a Notice of Appeal to the Patent Trial and Appeal Board (“PTAB” or “the Board”), alleging, among other things,…
2Cases cited13 opinions
- In Re Robert J. Gartside and Richard C. NortonCourt of Appeals for the Federal Circuit · 2000
- Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.Court of Appeals for the Federal Circuit · 2010
- Vas-Cath Incorporated and Gambro, Inc. v. Sakharam D. Mahurkar, and Quinton Instruments CompanyCourt of Appeals for the Federal Circuit · 1991
- Application of Heinrich Ruschig, Walter Aumuller, Gerhard Korger, Hans Wagner, Josef Scholz and Alfred BanderCourt of Customs and Patent Appeals · 1967
- In Re Scott T. JolleyCourt of Appeals for the Federal Circuit · 2002
8 more not listed; retrieve them via the Exa API.
3Cited by15 opinions
- Nike, Inc. v. Adidas AgCourt of Appeals for the Federal Circuit · 2016
- Erfindergemeinschaft UroPep GbR v. LillyDistrict Court, E.D. Texas · 2017
- Arthrex, Inc. v. Smith & Nephew, Inc.Court of Appeals for the Federal Circuit · 2022
- Unwired Planet, LLC v. Google Inc.Court of Appeals for the Federal Circuit · 2016
- General Hospital Corporation v. Sienna BiopharmaceuticalsCourt of Appeals for the Federal Circuit · 2018
10 more not listed; retrieve them via the Exa API.